PFE — Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Market Cap
- $156.77B
- P/E Ratio
- 20.16
- Beta
- 0.39
- 52-Week Range
- 21.87-28.75
- Dividend Yield
- $1.72
- CEO
- Albert Bourla
- Employees
- 81,000
- IPO Date
- Jun 1, 1972
- Exchange
- NYSE